These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22165786)

  • 21. Granulocyte colony stimulating factor treatment for delayed recovery of ticlopidine-related neutropenia.
    Hung MJ; Wang CH; Cherng WJ
    Int J Clin Pract; 2002; 56(1):70-1. PubMed ID: 11831843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Present and future indications of G-CSF in breast cancer].
    Chevallier B
    Pathol Biol (Paris); 1993 Jan; 41(1):47. PubMed ID: 7686285
    [No Abstract]   [Full Text] [Related]  

  • 23. Granulocyte colony-stimulating factor treatment for cyclophosphamide-induced severe neutropenia in Wegener's granulomatosis.
    Hellmich B; Schnabel A; Gross WL
    Arthritis Rheum; 1999 Aug; 42(8):1752-6. PubMed ID: 10446877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic intensification: contribution of G-CSF].
    Marty M; Extra JM; Giacchetti S
    Pathol Biol (Paris); 1993 Jan; 41(1):53-5. PubMed ID: 7686290
    [No Abstract]   [Full Text] [Related]  

  • 25. Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data.
    Gunzer K; Clarisse B; Lheureux S; Delcambre C; Joly F
    Expert Opin Biol Ther; 2010 Apr; 10(4):615-30. PubMed ID: 20218922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Granulocyte colony stimulating factor in the ambulatory treatment of neutropenia following chemotherapy].
    Ruiz LP; Aguila JD; Cedeño AM
    Rev Panam Salud Publica; 2009 Sep; 26(3):281-2. PubMed ID: 20058839
    [No Abstract]   [Full Text] [Related]  

  • 27. [Small cell lung cancer: value of G-CSF].
    Trillet V
    Pathol Biol (Paris); 1993 Jan; 41(1):46. PubMed ID: 7686284
    [No Abstract]   [Full Text] [Related]  

  • 28. [Questions on pneumology].
    Lebeau B
    Presse Med; 1998 Jul 4-11; 27(24):1211-2. PubMed ID: 9767774
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
    Garavelli PL
    Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
    Rossi JF
    Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
    [No Abstract]   [Full Text] [Related]  

  • 32. Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia.
    Jørgensen HG; Copland M; Holyoake TL
    Cancer; 2005 Jan; 103(1):210-11. PubMed ID: 15540243
    [No Abstract]   [Full Text] [Related]  

  • 33. [The use of a colony-stimulating factor (G-CSF) in iatrogenic neutropenias].
    Martínez Ruiz M; Llobell Segui G; Peralba Vaño JI; Toral Revuelta JR; Mellado del Rey F; González de Aledo GB
    An Med Interna; 1992 Dec; 9(12):624. PubMed ID: 1283082
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-interventional study for the treatment of neutropenia: Use of pegfilgrastim for chemotherapy-induced neutropenia].
    Wülfing C; Rexer H
    Urologe A; 2016 Jan; 55(1):76-7. PubMed ID: 26666910
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tongue ulcer in azidothymidine-induced neutropenia. Rapid increase in neutrophils and healing of the ulcer by substitution of recombinant human granulocyte colony stimulating factor (rhG-CSF)].
    Schwander S; Kern P
    Med Klin (Munich); 1993 Feb; 88(2):60-2. PubMed ID: 7680750
    [No Abstract]   [Full Text] [Related]  

  • 36. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
    Ersbøll J
    Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
    [No Abstract]   [Full Text] [Related]  

  • 37. [Economic evaluation of prophylaxis with recombinant granulopoiesis stimulating factor].
    Antoñanzas F; Rovira J; Garuz R; Antón F
    Med Clin (Barc); 1992 Nov; 99(18):685-9. PubMed ID: 1282638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USAN Council. List No.421. New names. Leridistim.
    Clin Pharmacol Ther; 1999 Nov; 66(5):545. PubMed ID: 10610270
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction of mesalazine-induced neutropenia with high-dose G-CSF.
    Bhidayasiri R; Katz JA; Sokos DR
    Am J Gastroenterol; 2000 Nov; 95(11):3321-2. PubMed ID: 11095375
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of severe neutropenias in dogs and cats with filgrastim].
    Kraft W; Kuffer M
    Tierarztl Prax; 1995 Dec; 23(6):609-13. PubMed ID: 8585081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.